Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2

A key element for the prevention and management of coronavirus disease 2019 is the development of effective therapeutics. Drug combination strategies offer several advantages over monotherapies. They have the potential to achieve greater efficacy, to increase the therapeutic index of drugs and to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeffreys, Laura N., Pennington, Shaun H., Duggan, Jack, Caygill, Claire H., Lopeman, Rose C., Breen, Alastair F., Jinks, Jessica B., Ardrey, Alison, Donnellan, Samantha, Patterson, Edward I., Hughes, Grant L., Hong, David W., O'Neill, Paul M., Aljayyoussi, Ghaith, Owen, Andrew, Ward, Stephen A., Biagini, Giancarlo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801767/
https://www.ncbi.nlm.nih.gov/pubmed/35093538
http://dx.doi.org/10.1016/j.ijantimicag.2022.106542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801767/
https://www.ncbi.nlm.nih.gov/pubmed/35093538
http://dx.doi.org/10.1016/j.ijantimicag.2022.106542

Ejemplares similares